OAT
Organic anion transporters are a family of membrane proteins that mediate the uptake and excretion of various endogenous and exogenous organic anions, including drugs, toxins, and metabolic byproducts. OATs are primarily expressed in the kidneys and liver, where they play a crucial role in detoxification and drug clearance. Dysregulation of OAT function can lead to drug toxicity and kidney disorders. At CymitQuimica, we provide a variety of OAT modulators to support your research in pharmacology, toxicology, and renal function.
Found 27 products of "OAT"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
URAT1 inhibitor 7
CAS:<p>URAT1 inhibitor 7, a uric acid transporter protein URAT1 inhibitor.URAT1 inhibitor 7 inhibits CYP2C9 and can be used in the study of hyperuricemia and gout.</p>Formula:C19H10ClFN4O3SPurity:97.65%Color and Shape:SoildMolecular weight:428.82Ruzinurad
CAS:<p>Ruzinurad (WO2020088641, compound I) is a potent URAT1 inhibitor, exhibiting high selectivity.</p>Formula:C14H12BrNO2SColor and Shape:SolidMolecular weight:338.22URAT1/GLUT9-IN-1
<p>URAT1/GLUT9-IN-1 (compound 29) effectively inhibits urate transporter 1 (URAT1) with an IC50 value of 2.01 μM and glucose transporter 9 (GLUT9) with an IC50 of 18.21 μM. This compound exhibits favorable pharmacokinetic properties and oral bioavailability, making it useful for research in gout and hyperuricemia.</p>URAT1 inhibitor 11
CAS:<p>URAT1 inhibitor11 (Compound 7) is a potent URAT1 inhibitor, exhibiting an IC50 of 0.18 μM. It effectively reduces uric acid levels in zebrafish with hyperuricemia induced by Potassium oxonate and Xanthinesodium salt.</p>Formula:C20H16F4N2O2Color and Shape:SolidMolecular weight:392.354'-hydroxy Trazodone
CAS:<p>4’-hydroxy Trazodone is a metabolite of the antidepressant and sedative trazodone.1It is an inhibitor of organic anion transporter 3 (OAT3; Ki= 16.9 μM) and is</p>Formula:C19H22ClN5O2Color and Shape:SolidMolecular weight:387.87Epaminurad HCl
CAS:<p>Epaminurad HCl is a URAT1 inhibitor with partial inhibition of OAT1 and OAT3 (organic anion transporters).Epaminurad HCl is a pro-uric acid excretory agent used for the prevention and treatment of gout and hyperuricemia.</p>Formula:C14H11Br2ClN2O3Purity:99.01% - 99.42%Color and Shape:SoildMolecular weight:450.51Lesinurad sodium
CAS:<p>Lesinurad sodium (RDEA594 sodium) is a selective inhibitor of uric acid reabsorption and is used in the study of cardiovascular diseases.</p>Formula:C17H13BrN3NaO2SPurity:99.97%Color and Shape:SolidMolecular weight:426.26Verinurad
CAS:<p>Verinurad (RDEA3170) (RDEA3170) is an organic anion transporter URAT1 (SLC22A12) inhibitor for the treatment of gout and hyperuricemia.</p>Formula:C20H16N2O2SPurity:97.36% - 99.22%Color and Shape:SolidMolecular weight:348.42Epaminurad
CAS:<p>Epaminurad (UR-1102) is an oral URAT1 inhibitor for gout research with a Ki of 0.057 μM, modestly affects OAT1/3.</p>Formula:C14H10Br2N2O3Color and Shape:SolidMolecular weight:414.05Cabotegravir
CAS:<p>Cabotegravir (S/GSK1265744) (GSK744, GSK1265744) is a long-acting HIV integrase inhibitor and inhibits the HIV-1 integrase catalyzed strand transfer reaction (</p>Formula:C19H17F2N3O5Purity:98.55% - 99.92%Color and Shape:SolidMolecular weight:405.35Dotinurad
CAS:<p>Dotinurad ((3,5-dichloro-4-hydroxyphenyl)(1,1-dioxidobenzo[d]thiazol-3(2H)-yl)methanone) is a potent agent of uricosuric (IC50: 3.6 μM for uric acid).</p>Formula:C14H9Cl2NO4SPurity:97.43% - 98.04%Color and Shape:SolidMolecular weight:358.2Lesinurad
CAS:<p>Lesinurad (RDEA594), a selective uric acid reabsorption inhibitor, is used to treat gout without causing liver damage.</p>Formula:C17H14BrN3O2SPurity:99.83% - 99.86%Color and Shape:SolidMolecular weight:404.28JTT-552
CAS:<p>JTT-552, a uric acid transporter 1 (URAT1) inhibitor, is used potentially for the treatment of hyperuricemia.</p>Formula:C15H12ClNO3Purity:98%Color and Shape:SolidMolecular weight:289.71URAT1 inhibitor 4
CAS:<p>URAT1 inhibitor 4 is a potent, orally active Lesinurad derivative with a 7.56 μM IC50, showing greater in vivo efficacy.</p>Formula:C27H20BrN3O4S3Color and Shape:SolidMolecular weight:626.56URAT1&XO inhibitor 2
CAS:<p>Compound BDEO (URAT1&XO inhibitor 2) serves as a dual-action inhibitor targeting both xanthine oxidase (XO) and URAT1, demonstrating an IC50 value of 3.3 μM for</p>Formula:C14H12BrNO3Purity:98%Color and Shape:SolidMolecular weight:322.15Xininurad
CAS:<p>Xininurad (XNW3009) is a urate transporter (URAT) inhibitor.</p>Formula:C15H10Br2FN3O2Color and Shape:SolidMolecular weight:443.07Puliginurad
CAS:<p>Puliginurad (YL-90148) is a urate transporter protein inhibitor that inhibits the reabsorption of uric acid.Puliginurad is used in the treatment of gout.</p>Formula:C19H16N2O2SPurity:99.96% - 99.96%Color and Shape:SolidMolecular weight:336.41Lingdolinurad
CAS:<p>Lingdolinurad is a uric acid transporter protein inhibitor targeting hURAT1 for the study of hyperuricemia or gout.</p>Formula:C17H12BrN3O2Purity:96.26%Color and Shape:SolidMolecular weight:370.2URAT1 inhibitor 6
CAS:<p>URAT1 inhibitor 6 (Compound 1h), with an IC50 of 35 nM for hURAT1, demonstrates 200-fold and 8-fold greater potency compared to Lesinurad and Benzbromarone,</p>Formula:C9H7BrN3NaO2S2Color and Shape:SolidMolecular weight:356.2URAT1 inhibitor 8
CAS:<p>URAT1 Inhibitor 8 (example 247) serves as a highly potent inhibitor of URAT1, demonstrating an IC50 value of 0.001 μM.</p>Formula:C19H13ClFN3O4SColor and Shape:SolidMolecular weight:433.84
